T cell therapy shows promise against acute adult leukemia

03/21/2013 | New York Times (tiered subscription model), The

A cellular therapy has induced remission in a deadly form of adult acute leukemia, Memorial Sloan-Kettering Cancer Center researchers reported in the journal Science Translational Medicine. The therapy uses disabled viruses to program T cells to attack B cells, and it has been used to treat other forms of leukemia. "This is the first report showing some real, clinically beneficial activity in adult acute lymphoblastic leukemia," said Dr. Carl June of the University of Pennsylvania, who is developing a similar treatment.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD